A new way of defining clinical endpoints with Sébastien Coppe

Join host Sylvain Berthelot and Sébastien Coppe, CEO and co-founder of One2Treat, to explore a patient-focused approach to redefining clinical endpoints. Drawing from his background in optimizing clinical supply chains and his passion for involving patients more deeply in trial design, Sébastien shares how One2Treat is using technology to bring the patient’s voice into the earliest stages of clinical development.

The discussion touches on the limitations of traditional endpoints, the value of co-designing studies with patients, and the promise of tools that capture lived experiences to define outcomes that truly matter. Sébastien emphasizes the need to rethink how we measure success in trials, through real-world impact and patient relevance.

Tune in to discover how new statistical approaches are enabling a more meaningful way to define what good looks like in clinical research.

Watch the full webinar

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

The reality of data fragmentation in clinical trials with Kavita Gaadhe

Why clinical teams transition from legacy systems to CRScube

As the industry moves toward faster, more decentralized models, many teams find that the tools which once supported them now require significant manual workarounds to stay current.

From "Wow" to "How": What your questions taught us about the future of AI in clinical trials

While presenting our AI-led EDC setup functionality, we were impressed by the questions asked and what they reveal about our clients' readiness for AI-driven technology.